LeMaitre Vascular, Inc.

LMAT Healthcare Medical Instruments & Supplies

LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.

Revenue
+11.3%
EPS
−14.3%
Free cash flow
−25.8%
Total debt
+0.53%

Quarter to September 2026, against a year earlier

80.99 2.50 −2.99%
Market cap
$1.9B
P/E
29.7×
Fwd P/E
28.2×
Dividend yield
1.15%
F-score
6/9
Altman Z
6.99
Beneish M
−2.61
Dividend safety
93/100

LeMaitre Vascular, Inc. (LMAT) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, LeMaitre Vascular, Inc. (LMAT) trades at a EV/FCF of 25.1×. Over the past ten years it has ranged from 18.8× (July 2016) to 76.2× (June 2023); the current reading is higher than 12% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 22.1× (57.61%)
FY2024 52.2× 31.30%
FY2023 39.8× (2.05%)
FY2022 40.6× 21.43%
FY2021 33.4× 36.09%
FY2020 24.6× (63.27%)
FY2019 66.9× 167.24%
FY2018 25.0× (25.02%)
FY2017 33.4× 5.95%
FY2016 31.5× 3.40%

Quarterly newest first

Period EV/FCF Change
Sep 2026 25.0× (7.41%)
Jun 2026 27.0× (7.05%)
Mar 2026 29.0× 30.96%
Dec 2025 22.1× (19.07%)
43 more quarters

Against its own ten years

Low 18.8× High 76.2×
Ten-year median 33.5×
Current reading's percentile 10

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on LMAT